BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38216404)

  • 1. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
    de-Torres JP; Alcaide AB; Campo A; Zulueta JJ; Bastarrika G; Ezponda A; Mesa M; Murillo D; Rodriguez M; Del Mar Ocón M; Felgueroso C; Pueyo J; Lozano MD; Montuenga LM; Berto J; Perez-Warnisher MT; Di-Frisco IM; Seijo LM
    Arch Bronconeumol; 2024 Feb; 60(2):95-100. PubMed ID: 38216404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
    Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
    Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
    Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
    BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD phenotypes in a lung cancer screening population.
    Balkan A; Bulut Y; Fuhrman CR; Fisher SN; Wilson DO; Weissfeld JL; Sciurba FC
    Clin Respir J; 2016 Jan; 10(1):48-53. PubMed ID: 24989058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 11. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used.
    Jögi J; Markstad H; Tufvesson E; Bjermer L; Bajc M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():25-30. PubMed ID: 25565797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease.
    Lim J; Shin KM; Lee K; Lim JK; Kim HJ; Cho SH; Cha SI
    AJR Am J Roentgenol; 2015 Sep; 205(3):540-5. PubMed ID: 26295639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel CT-emphysema index/FEV
    Loh LC; Ong CK; Koo HJ; Lee SM; Lee JS; Oh YM; Seo JB; Lee SD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2543-2550. PubMed ID: 30174423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Computed Tomography Assessment of Pectoralis and Erector Spinae Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease Referred for Lung Volume Reduction.
    Attaway AH; Welch N; Yadav R; Bellar A; Hatipoğlu U; Meli Y; Engelen MPKJ; Zein J; Dasarathy S
    COPD; 2021 Apr; 18(2):191-200. PubMed ID: 33736550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
    Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA;
    Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for FEV
    Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray dark-field chest imaging for detection and quantification of emphysema in patients with chronic obstructive pulmonary disease: a diagnostic accuracy study.
    Willer K; Fingerle AA; Noichl W; De Marco F; Frank M; Urban T; Schick R; Gustschin A; Gleich B; Herzen J; Koehler T; Yaroshenko A; Pralow T; Zimmermann GS; Renger B; Sauter AP; Pfeiffer D; Makowski MR; Rummeny EJ; Grenier PA; Pfeiffer F
    Lancet Digit Health; 2021 Nov; 3(11):e733-e744. PubMed ID: 34711378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.